Fatigue after treatment in breast cancer survivors: prevalence, determinants and impact on health-related quality of life
- 913 Downloads
Fatigue is a phenomenon that may persist for years after completion of adjuvant therapy, and is one of the most frequent symptoms associated with breast cancer survivors. The purposes of this study were to investigate the occurrence of fatigue in disease-free breast cancer survivors after treatment, to identify variables associated with fatigue, and to evaluate the impact of fatigue on health-related quality of life.
A cross-sectional study was conducted on 202 consecutive women diagnosed with in-situ to Stage III breast cancer attending in outpatient facilities of two large hospitals, one year or more after diagnosis. They completed the Piper Fatigue Scale-Revised and the European Organization for Research and Treatment of Cancer QLQ-C30. Multiple logistic regression models were used to identify predictive factors associated with fatigue. EORTC QLQC-30 scores for fatigued survivors were compared to non-fatigued survivors.
The prevalence of fatigue reported by the breast cancer survivors was 37.6%. Multiple logistic regression analysis revealed that predictive factors for fatigue included younger age (odds ratio [OR]=2.23, 95% confidence interval [CI]=1.11–4.45, p = 0.024); presence of pain (OR = 3.87, 95% CI = 1.88-7.98, p = 0.000); dyspnea (OR = 3.72, 95% CI = 1.46–9.50, p = 0.006); insomnia (OR = 2.40, 95% CI = 1.19–4.86, p = 0.015); and nausea and vomiting (OR = 12.25, 95% CI = 1.18–126.75, p = 0.036). Fatigued women had poorer health-related quality of life than non-fatigued women in all domains.
Our results suggest that many disease-free breast cancer survivors after treatment experienced fatigue that compromises their health-related quality of life.
KeywordsBreast cancer Fatigue Quality of life Survivors Predictors Prevalence
We thank all the women who took part in this research.
Conflicts of interest
The authors of this study did not receive any financial support for this study and declare no conflict of interest.
- 2.Instituto Nacional do Câncer (National Institute of Cancer)-Brasil (2009) Incidence estimative in Brazil 2010. http://www.inca.gov.br/estimativa/2010/estimativa20091201.pdf. Accessed 14 May 2010
- 3.American Cancer Society (2010) Cancer Facts & Figures 2010. http://www.cancer.org/acs/groups/content/@epidemiologysurveilance/documents/document/acspc-026238.pdf. Accessed 01 December 2010
- 11.Goldstein D, Bennett B, Friedlander M et al (2006) Fatigue states after cancer treatment occur both in association with, and independent of, mood disorder: a longitudinal study. BMC Cancer. doi: 10.1186/1471-2407-6-240
- 29.Fayers PM, Aaronson NK, Bjordal K et al (2001) European Organisation for Research and Treatment of Cancer QLQ-C30 Scoring Manual, 3rd edn. EORTC Quality of Life Group, BrusselsGoogle Scholar
- 34.Mock V, Atkinson A, Barsevick A et al (2000) NCCN practice guidelines for cancer-related fatigue. Oncology (Huntingt) 14:151–161Google Scholar
- 36.Ahn SH, Park BW, Noh DY et al (2007) Health-related quality of life in disease-free survivors of breast cancer with the general population. Ann Oncol 18:173e182Google Scholar